Novelis Inc. 8-K

What Happened

• Novelis Inc. filed a Form 8-K disclosing two material actions in February 2026. On February 19, 2026 the company amended its Second Amended and Restated Credit Agreement (the ABL Facility) to increase the maximum revolving amount by $500.0 million, raising the total revolver capacity to $2,500.0 million. On February 18, 2026 Novelis entered into a subscription agreement with AV Minerals (Netherlands) N.V. (its sole shareholder and a Hindalco subsidiary) under which AV Minerals purchased 1,333,333 common shares for $199,999,950 at $150.00 per share; the investment closed concurrently with the agreement.

Key Details

• ABL Amendment effective Feb 19, 2026 increases the ABL Facility revolving commitment by $500.0 million to $2,500.0 million; Wells Fargo Bank, N.A. serves as administrative and collateral agent.
• Subscription agreement dated Feb 18, 2026: AV Minerals purchased 1,333,333 common shares for $199,999,950 (price = $150/share).
• The common shares were sold in a private placement (not registered) under Section 4(a)(2) and/or Regulation D of the Securities Act.
• The ABL Amendment leaves all other material terms of the ABL Facility unchanged; the company will file the full ABL Amendment as an exhibit to its Form 10-K.

Why It Matters

• The $500 million increase in the revolver expands Novelis’ available short-term liquidity and borrowing capacity to $2.5 billion, which affects the company’s financial flexibility for working capital, capital expenditures, or debt management.
• The ~$200 million equity subscription increases the company’s cash/equity capital and reflects continued financial support from its parent, AV Minerals/Hindalco.
• Both actions are concrete, non-operational capital-structure moves that retail investors should note when assessing Novelis’ liquidity position and balance-sheet strength; the equity sale was a private placement and not registered for public resale.